⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6298214 | 0.79 | — | — | |
| SCHEMBL10425429 | 0.75 | TP53 (0.33) | — | |
| SCHEMBL9190572 | 0.74 | — | — | |
| SCHEMBL5856225 | 0.74 | CA2 (0.39) | — | |
| Dimethylamine SCHEMBL28075516 | 0.74 | — | — | |
| SCHEMBL5138135 | 0.72 | CA2 (0.42) | — | |
| SCHEMBL5136293 | 0.72 | CA2 (0.42) | — | |
| SCHEMBL7715442 | 0.72 | CA2 (0.42) | — | |
| SCHEMBL5136467 | 0.72 | CA2 (0.42) | — | |
| SCHEMBL29278632 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025122770-A1 | STENTS AND TOPICAL COMPOSITIONS COMPRISING THIOSULFATE | SHIN MICHAEL (US) | 2025-06-12 | — | — | WO | disclosed |
| CN-119100946-A | Synthesis method of key intermediate of rilpivirine | 石家庄龙泽制药股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-118285384-A | In-situ fumigation method for controlling mold disease of tomb wall painting | 中国科学院上海有机化学研究所 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024078569-A1 | AROMATIC AMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 浙江海正药业股份有限公司 | 2024-04-18 | — | — | WO | disclosed |
| CN-112321805-B | Indacen-4-one derivatives, process for their preparation and polymers containing them | 艾尼股份公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-115135642-A | Inhibitors of mutant forms of EGFR | 缆图药品公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-114478528-A | Aroyl-substituted tricyclic compound, preparation method and application thereof | 劲方医药科技(上海)有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-114364378-A | Cancer immunotherapy | 阿克塞利阿肿瘤学私人有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-102633702-B | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2014-01-15 | — | — | CN | disclosed |
| CN-102633702-B | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2014-01-15 | — | — | CN | disclosed |
| CN-102633702-A | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2012-08-15 | — | — | CN | disclosed |
| CN-102633702-A | Beta-amino ethyl thiosulfuric acid and synthesis method thereof | GUANGZHOU JENYI BIO TECH CO LTD | 2012-08-15 | — | — | CN | disclosed |
| EP-2399131-A2 | METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2011-12-28 | — | — | EP | disclosed |
| WO-2010096713-A2 | METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2010-08-26 | — | — | WO | disclosed |
| EP-0822958-B1 | HALOGENATED ELASTOMER COMPOSITIONS | MONSANTO CO (US) | 2001-06-20 | — | — | EP | disclosed |
| US-6207764-B1 | ELASTOMERIC INTERPOLYMERS CONTAINING HALOGENATED COPOLYMER OF C4-C7 ISOOLEFIN AND PARA-ALKYLSTYRENE, A CROSSLINKING AGENT AND A THIOSULFATE ACCELERATOR | MONSANTO COMPANY | 2001-03-27 | — | — | US | disclosed |
| EP-0822958-A1 | HALOGENATED ELASTOMER COMPOSITIONS | MONSANTO COMPANY (US) | 1998-02-11 | — | — | EP | disclosed |
| WO-1996034043-A1 | HALOGENATED ELASTOMER COMPOSITIONS | MONSANTO COMPANY (US) | 1996-10-31 | — | — | WO | disclosed |